Investors / United Kingdom / Hikma Ventures
Hikma Ventures
Corporate VC · London, United Kingdom · Europe
Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, founded in 2015 as a $100m evergreen fund. It invests in digital health and life sciences companies and partners with them by leveraging Hikma's expertise and reach as a global generics pharmaceutical company.
Invests inHealthcare & Biotech
In its own wordsdigital healthlife sciencesdrug deliverydigital therapeuticsclinical trialspharmaceuticals
Your fit with Hikma Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsHikma Ventures lists 17 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Growth, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (88%), AI & Machine Learning (6%) and Industrial & Manufacturing (6%). 75% of its companies are based in United States. It invests most often alongside ARTIS, Creative Destruction Lab and Sanofi Ventures.
Counts come from funding rounds that name Hikma Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Hikma Ventures' whole history. Rounds on record name 1 company; its own site lists 17. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 0% |
| Growth | 100% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 42th | 16 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 68th | 6% of companies confirmed by a round |
| Sector focus | 95th | 88% in its largest sector |
| Reach | 59th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| ARTIS | 2 |
| Creative Destruction Lab | 2 |
| Sanofi Ventures | 2 |
| 7G BioVentures | 1 |
| Able Partners | 1 |
| Accel | 1 |
| AlbionVC | 1 |
| Alpana Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1694%
- No longer answers00%
- Points to another company16%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 88% | 15% |
| AI & Machine Learning | 6% | 18% |
| Industrial & Manufacturing | 6% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare Hikma Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Hikma Ventures| Date | Company | Stage |
|---|---|---|
| 4 Sept 2025 | Series C+ |
Round details for Hikma Ventures
Amounts, full round histories and every co-investor in Hikma Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
17 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Activ Surgical develops and provides real-time surgical intelligence for surgeons and platforms | Healthcare & Biotech | Portfolio page | ||
| The company provides medical information and consultation services | Healthcare & Biotech | Portfolio page | ||
| Altoida develops a digital platform to detect early cognitive decline and provide neurological diagnostics | Healthcare & Biotech | Portfolio page | ||
| Biolinq develops and manufactures a fully autonomous, needle-free glucose sensor | Healthcare & Biotech | Portfolio page | ||
| Click Therapeutics develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. | Healthcare & Biotech | Portfolio page | ||
| Ermit develops and builds physical AI products, including connected devices, real-time intelligence, and human interfaces | AI & Machine LearningIndustrial & Manufacturing | Portfolio page | ||
| The company develops biologics and peptides for various diseases, including obesity and cardio-renal-metabolic diseases. | Healthcare & Biotech | Portfolio page | ||
| The company provides online doctor and telehealth services. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Nebula Genomics offers whole genome DNA tests for health and ancestry reports | Healthcare & Biotech | Portfolio page | ||
| NuvoAir provides medical care and monitoring services for patients with lung and sleep health conditions. | Healthcare & Biotech | Portfolio page | ||
| O7 provides online therapy and mental health support services. | Healthcare & Biotech | Portfolio page | ||
| Octave Bioscience develops and provides a blood test to measure multiple sclerosis disease activity | Healthcare & Biotech | Sept 2025Series C+ | Page + round | |
| Prognos harmonizes and enriches lab data, connecting patient and provider context for the decisions ahead | Healthcare & Biotech | Portfolio page | ||
| SeamlessMD keeps patients on track with timely reminders, education, and symptom monitoring | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Winterlight has developed a tablet-based assessment that analyzes speech to detect cognitive impairment associated with dementia and mental illness. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- hikmaventures.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 4 Sept 2025
- Companies checked
- 17
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Hikma Ventures' profile as data
Pull Hikma Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/hikmaventures.com
# also
GET /v1/firms/hikmaventures.com/portfolio
GET /v1/firms/hikmaventures.com/coinvestors
GET /v1/firms/hikmaventures.com/news